These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3123880)

  • 1. Construction of immunotoxins using Pseudomonas exotoxin A.
    FitzGerald DJ
    Methods Enzymol; 1987; 151():139-45. PubMed ID: 3123880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas exotoxin--immunotoxins.
    FitzGerald DJ; Willingham MC; Pastan I
    Cancer Treat Res; 1988; 37():161-73. PubMed ID: 2908624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immunotoxins active against ovarian cancer cell lines.
    Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Laird W; Frankel AE; Willingham MC; Pastan I
    J Clin Invest; 1985 Sep; 76(3):1261-7. PubMed ID: 3930572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.
    Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3358-62. PubMed ID: 2014255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.
    Debinski W; Pastan I
    Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
    Weldon JE; Xiang L; Chertov O; Margulies I; Kreitman RJ; FitzGerald DJ; Pastan I
    Blood; 2009 Apr; 113(16):3792-800. PubMed ID: 18988862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.
    Choe M; Webber KO; Pastan I
    Cancer Res; 1994 Jul; 54(13):3460-7. PubMed ID: 8012967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D; Pastan I
    Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.
    Cryz SJ; Fürer E; Sadoff JC; Germanier R; Pastan I; Willingham MC; FitzGerald DJ
    Rev Infect Dis; 1987; 9 Suppl 5():S644-9. PubMed ID: 3120274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Resistance to Immunotoxins Containing
    Dieffenbach M; Pastan I
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32630017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.
    Kondo T; FitzGerald D; Chaudhary VK; Adhya S; Pastan I
    J Biol Chem; 1988 Jul; 263(19):9470-5. PubMed ID: 3132465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice.
    Kreitman RJ; Hansen HJ; Jones AL; FitzGerald DJ; Goldenberg DM; Pastan I
    Cancer Res; 1993 Feb; 53(4):819-25. PubMed ID: 8428363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
    Weldon JE; Pastan I
    FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention.
    Fleming BD; Urban DJ; Hall MD; Longerich T; Greten TF; Pastan I; Ho M
    Hepatology; 2020 May; 71(5):1696-1711. PubMed ID: 31520528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective elimination of breast cancer cells from human bone marrow using an antibody-Pseudomonas exotoxin A conjugate.
    Bjorn MJ; Manger R; Sivam G; Morgan AC; Torok-Storb B
    Cancer Res; 1990 Sep; 50(18):5992-6. PubMed ID: 2118424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies.
    Mansfield E; Pastan I; FitzGerald DJ
    Bioconjug Chem; 1996; 7(5):557-63. PubMed ID: 8889017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins.
    Brinkmann U; Brinkmann E; Pastan I
    Mol Med; 1995 Jan; 1(2):206-16. PubMed ID: 8529099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of caspases in immunotoxin-induced apoptosis of cancer cells.
    Keppler-Hafkemeyer A; Brinkmann U; Pastan I
    Biochemistry; 1998 Dec; 37(48):16934-42. PubMed ID: 9836586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U; Lee BK; Pastan I
    J Immunol; 1993 Apr; 150(7):2774-82. PubMed ID: 8454854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.